7 results about "Cell immortalization" patented technology

The application discloses an exosome drug delivery system with anti-phagocytosis and tumor targeting ability as well as a preparation method and application thereof. A tumor targeting group is flexibly connected to the outside of the cell membrane of a transmembrane protein with anti-phagocytosis ability through a linker of a fusion protein. A fusion gene sequence is designed and inserted into an expression vector to form a fusion expression vector, which is integrated into the chromosome of a cell to be modified to obtain an engineered cell stably expressing the fusion protein, which is used for secreting engineered exosomes. The cell to be modified includes a naked cell (an immortalized cell line, a primary cell), an engineered cell stably expressing a therapeutic nucleic acid molecule or a protein. The exosomes produced by the former cell can further package the therapeutic molecules to treat tumors, and the exosomes produced by the latter cell can be directly used for treating tumors after being separated, purified and collected. The half-life of the engineered exosomes produced by the application is significantly prolonged in the body, the treatment effect is improved, and the exosomes show strong tumor targeting and anti-tumor effects in vivo and in vitro.

A DNA immortalization construct includes a first nucleic acid sequence derived from the 5′ end of human CDKN2A gene exon 2. An EF1α promoter sequence is connected to the first sequence. A first LoxP sequence is connected to the EF1α promoter sequence. A human TERT gene sequence is connected to the first LoxP sequence. A second LoxP sequence is connected to the human TERT gene sequence. An internal ribosomal entrance site (IRES) sequence is connected to the second LoxP sequence. An antibiotic selection gene sequence is connected to the IRES sequence. An SV40 poly-A signal sequence is connected to the antibiotic selection gene sequence. A second nucleic acid sequence is connected to the SV40 poly-A signal sequence and derived from 3′ end of human CDKN2A gene exon 2.

The present invention relates to an immortalized telocyte cell line, to methods for its preparation which include immortalizing intestine-derived cells labeled with a Foxll -driven reporter gene, and uses of the cell line including for supporting organoid growth.

A method for extending the replicative lifespan of T cells by activating the TERT gene is provided. Particularly, the method involves the epigenetic modification of the TERT promoter using a CRISPR / dCas9-based epigenetic modifier, followed by the reactivation of the modified TERT promoter using a Cas9-mediated transcriptional activator.

The invention discloses a Putian subpigskin precursor fat cell immortalized cell line, a preparation method and application, and relates to the technical field of immortalized cells, and the method is characterized in that the immortalized Putian subpigskin precursor fat cell line is established by using an SV40T lentivirus infection system; the differentiation capacity of precursor fat cells is continuously reserved, the tumorigenesis tendency does not occur, and the cell line belongs to a normal cell line. The cell line not only can provide a stable breed conservation material for protecting genetic resources of Putian pigs, but also is beneficial to providing a reliable biological material for exploring a pig fat deposition molecular mechanism.

Provided are a B-cell immortalization-based method for developing a single B-cell antibody and the use thereof. The provided method comprises the following steps: S1, antigen preparation; S2, antigen immunization; S3, modification of a lentiviral vector; S4, viral infection and cell sorting; S5, screening for cells with a high binding activity; S6, sequencing of an antibody sequence; S7, activity verification of a target antibody, etc. The provided antibody development method effectively solves the problems that single B-cell antibody development requires extensive recombinant expression and incurs a high verification cost. By combining single B-cell technology with B-cell immortalization technology, a B cell is infected by using a modified lentivirus, so that the cell achieves immortalization and enables in vitro proliferation and antibody secretion. Furthermore, by combining high-throughput microfluidic screening with cell immortalization technology, cell infection is performed directly in an oil droplet, thereby achieving high-throughput and low-cost antibody development.

The invention discloses a construction method and application of a matrigel suppository telocyte immortalized cell line, which comprises the following steps: recruiting in vivo matrigel suppository, sorting telocytes by CD34 immunomagnetic beads, and combining SV40T transduction to establish the telocyte immortalized cell line. And carrying out morphological observation, specific marker detection and functional verification to identify that the obtained cell line is the teterocyte. According to the construction method, the teterocyte closer to the in-vivo functional state can be efficiently obtained, and the obtained cell line can be stably passaged for a long time and maintain the morphological characteristics and biological functions of primary cells; a stable and reliable tool is provided for in-vitro research such as subcutaneous microenvironment research, drug screening and cell therapy, tissue engineering and regenerative medicine and continuous in-depth research in related fields, and the method has wide application value in multiple scientific research fields such as tissue engineering model construction, intercellular interaction research and drug effect evaluation.